Position in ACET
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,297,764
+$713,820 QoQ
Shares Held
265,945
+14.3% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 56 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names. ACET ranks #124 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ACET
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,297,764 | 265,945 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,583,944 | 232,591 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,045,596 | 242,945 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,481,448 | 1,828,949 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $703,827 | 1,153,816 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $612,078 | 810,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $881,673 | 916,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,773,504 | 1,231,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,830,246 | 1,512,600 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,465,150 | 1,049,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,448,874 | 766,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $927,490 | 677,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $511,279 | 210,403 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,819,008 | 315,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $265,518 | 29,700 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $1,832,300 | 125,500 | Shares | Sole | 2022-08-12 | |
| 2021-09-30 | $330,981 | 42,217 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $840,693 | 81,700 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $262,908 | 20,100 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||